高血压与糖尿病以及福辛普利与氨氯地平心血管事件试验（FACET）。反对替代终点的更多依据。 - Suppr

Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points.

Califf R M, Granger C B

Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.

Diabetes Care. 1998 Apr;21(4):655-7. doi: 10.2337/diacare.21.4.655.

Abstract

摘要

Diabetes Care. 1998 Apr;21(4):655-7. doi: 10.2337/diacare.21.4.655.

Am J Cardiol. 1999 Mar 1;83(5):819-20. doi: 10.1016/s0002-9149(99)00035-1.

Am J Cardiol. 1998 Nov 12;82(9B):15R-19R. doi: 10.1016/s0002-9149(98)00751-6.

Diabetes Care. 1998 Apr;21(4):597-603. doi: 10.2337/diacare.21.4.597.

J Fam Pract. 1998 Jul;47(1):12-3.

Am Fam Physician. 1999 Sep 15;60(4):1102, 1104, 1107.

Am J Hypertens. 2002 Dec;15(12):1042-9. doi: 10.1016/s0895-7061(02)03017-0.

Lancet. 1998 Mar 7;351(9104):689-90. doi: 10.1016/S0140-6736(05)78489-0.

Med Pregl. 2004 Jan-Feb;57(1-2):45-53. doi: 10.2298/mpns0402045p.

Eur Heart J. 2000 Jan;21(1):2-7. doi: 10.1053/euhj.1999.1833.

Pharmacoeconomics. 2004;22(1):9-28. doi: 10.2165/00019053-200422010-00002.

Curr Hypertens Rep. 1999 Dec;1(6):512-20. doi: 10.1007/s11906-996-0024-9.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。